Stay updated on GECKO Clinical Trial: MOR106 + Topical Corticosteroids
Sign up to get notified when there's something new on the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page.

Latest updates to the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a routine site update and does not modify study information on the page.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding/operating status notice that previously appeared on the page.SummaryDifference0.4%

- Check34 days agoChange DetectedThe page now shows a termination notice stating that MOR106 development in atopic dermatitis was stopped for futility. This update appears in the Study Overview and updates the study's status and related details.SummaryDifference0.4%

- Check63 days agoChange DetectedSignificant changes: updated operating status notice and version to v3.2.0; removed previous v3.1.0 reference.SummaryDifference4%

- Check70 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.6%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to GECKO Clinical Trial: MOR106 + Topical Corticosteroids
Enter your email address, and we'll notify you when there's something new on the GECKO Clinical Trial: MOR106 + Topical Corticosteroids page.